Product Program year 2020 Source: CMS Open Payments

Gliadel

Drug Neurology

NDC 6285-6177-08

Open in the dashboard

General payments

$11,351

803 payments

Research payments

$371,893

135 payments

Through program year 2020, $11,351 in general payments and $371,893 in research payments were reported against Gliadel (Neurology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2020 Research $118,886 42
2019 General $11,351 803
2019 Research $253,007 93

Breakdown

Who paid General payments · program year 2019
  1. Arbor Pharmaceuticals, Inc. $11,351 803 payments
Top recipients General payments · program year 2019
  1. Timothy Ryken Neurological Surgery · Des Moines, IA $998 9% · 2 payments
  2. Steven Kalkanis Neurological Surgery · Detroit, MI $998 9% · 2 payments
  3. Kevin Lillehei Neurological Surgery · Aurora, CO $338 3% · 2 payments
  4. Jeffrey Olson Neurological Surgery · Atlanta, GA $336 3% · 2 payments
  5. Nina Paleologos Neurology · Downers Grove, IL $333 3% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Neurological Surgery $9,627 85% · 245 practitioners
  2. Neurology Psychiatry & Neurology $558 5% · 13 practitioners
  3. Pediatric Endocrinology Pediatrics $206 2% · 7 practitioners
  4. Sports Medicine Orthopaedic Surgery $126 1% · 1 practitioner
  5. Radiation Oncology Radiology $91 <1% · 6 practitioners

The top 5 of 26 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Michigan $1,392 12% · 18 recipients
  2. New York $1,007 9% · 23 recipients
  3. New Hampshire $998 9% · 1 recipient
  4. North Carolina $961 8% · 29 recipients
  5. Georgia $848 7% · 14 recipients

The top 5 of 33 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

803 general · 135 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record